Gynecologic and Obstetric Investigation
Case Report
The Keeper®, a Menstrual Collection Device, as a Potential Cause of Endometriosis and AdenomyosisSpechler S.a · Nieman L.K.a · Premkumar A.b · Stratton P.aaPediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, Bethesda, Md., and bDepartment of Radiology, Clinical Center, National Institutes of Health, Bethesda, Md., USA
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Access via DeepDyve
- Unlimited fulltext viewing Of this article
- Organize, annotate And mark up articles
- Printing And downloading restrictions apply
Article / Publication Details
Received: July 03, 2002
Accepted: June 02, 2003
Published online: August 29, 2003
Issue release date: August 2003
Number of Print Pages: 3
Number of Figures: 2
Number of Tables: 0
ISSN: 0378-7346 (Print)
eISSN: 1423-002X (Online)
For additional information: https://www.karger.com/GOI
Abstract
Barrier contraceptive devices like the cervical cap and diaphragm and menstrual collecting devices may block menstrual flow, increase retrograde menstruation, and thus theoretically increase the likelihood of developing endometriosis or adenomyosis. We describe the case of a woman with a prior tubal ligation who after 4 years of regular use of the Keeper®, a menstrual collecting device, developed adenomyosis and endometriosis.
© 2003 S. Karger AG, Basel
References
-
Sampson JA: Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927;14:422–469.
- D’Hooghe TM, Bambra CS, Raeymaekers BM, De Jonge I, Lauweryns JM, Koninckx PR: Intrapelvic injection of menstrual endometrium causes endometriosis in baboons (Papio cynocephalus and Papio anubis). Am J Obstet Gynecol 1995;173:125–134.
- Vercellini P, Ragni G, Trespidi L, Oldani S, Crosignani PG: Does contraception modify the risk of endometriosis? Hum Reprod 1993;8:547–551.
- Parazzini F, Ferrraroni M, Bocciolone L, Tozzi L, Rubessa S, La Vecchia C: Contraceptive methods and risk of pelvic endometriosis. Contraception 1994;49:47–55.
-
Morrissey K, Idriss N, Nieman L, Winkel C, Stratton P: Dysmenorrhea after bilateral tubal ligation: A case of retrograde menstruation. Obstet Gynecol 2002;100:1065–1067.
External Resources
-
Cramer DW, Missmer SA: The epidemiology of endometriosis. Ann N Y Acad Sci 2002;955:11–22.
External Resources
-
Cheng M, Kung R, Hannah M, Wilansky D, Shime J: Menses cup evaluation study. Fertil Steril 1995;64:661–663.
External Resources
-
Byun JY, Kim SE, Choi BG, Ko GY, Jung SE, Choi KH: Diffuse and focal adenomyosis: MR imaging findings. Radiographics 1999;19(suppl):161–170.
Article / Publication Details
Received: July 03, 2002
Accepted: June 02, 2003
Published online: August 29, 2003
Issue release date: August 2003
Number of Print Pages: 3
Number of Figures: 2
Number of Tables: 0
ISSN: 0378-7346 (Print)
eISSN: 1423-002X (Online)
For additional information: https://www.karger.com/GOI
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission